A 0 1 0 1 O
confirmed 2 11 2 11 O
tumor 12 17 12 17 B-cancer
site 18 22 18 22 O
is 23 25 23 25 O
one 26 29 26 29 O
which 30 35 30 35 O
is 36 38 36 38 O
biopsy 39 45 39 45 B-treatment
- 45 46 45 46 O
proven 46 52 46 52 O

A 0 1 53 54 O
pregnancy 2 11 55 64 B-pregnancy
test 12 16 65 69 O
will 17 21 70 74 O
be 22 24 75 77 O
performed 25 34 78 87 O
on 35 37 88 90 O
each 38 42 91 95 O
premenopausal 43 56 96 109 O
female 57 63 110 116 B-gender
of 64 66 117 119 O
childbearing 67 79 120 132 O
potential 80 89 133 142 O
immediately 90 101 143 154 O
prior 102 107 155 160 O
to 108 110 161 163 O
entry 111 116 164 169 O
into 117 121 170 174 O
the 122 125 175 178 O
research 126 134 179 187 O
study 135 140 188 193 O

Male 0 4 194 198 B-gender

Patients 0 8 199 207 O
must 9 13 208 212 O
agree 14 19 213 218 B-contraception_consent
to 20 22 219 221 I-contraception_consent
use 23 26 222 225 I-contraception_consent
a 27 28 226 227 I-contraception_consent
medically 29 38 228 237 I-contraception_consent
effective 39 48 238 247 I-contraception_consent
method 49 55 248 254 I-contraception_consent
of 56 58 255 257 I-contraception_consent
contraception 59 72 258 271 I-contraception_consent
during 73 79 272 278 O
and 80 83 279 282 O
for 84 87 283 286 O
a 88 89 287 288 O
period 90 96 289 295 O
of 97 99 296 298 O
three 100 105 299 304 B-upper_bound
months 106 112 305 311 I-upper_bound
after 113 118 312 317 O
the 119 122 318 321 O
treatment 123 132 322 331 B-treatment
period 133 139 332 338 O

Patients 0 8 339 347 O
must 9 13 348 352 O
have 14 18 353 357 O
a 19 20 358 359 O
Karnofsky 21 30 360 369 B-clinical_variable
performance 31 42 370 381 I-clinical_variable
status 43 49 382 388 I-clinical_variable
≥70 50 53 389 392 O
% 53 54 392 393 I-lower_bound
( 55 56 394 395 O
or 56 58 395 397 O
the 59 62 398 401 O
equivalent 63 73 402 412 O
ECOG 74 78 413 417 B-clinical_variable
level 79 84 418 423 I-clinical_variable
of 85 87 424 426 O
0 88 89 427 428 O
- 89 90 428 429 O
2 90 91 429 430 B-upper_bound
) 91 92 430 431 O
and 93 96 432 435 O
an 97 99 436 438 O
expected 100 108 439 447 B-clinical_variable
survival 109 117 448 456 I-clinical_variable
of 118 120 457 459 O
≥ 121 122 460 461 O
three 123 128 462 467 B-lower_bound
months 129 135 468 474 I-lower_bound

Patients 0 8 475 483 O
must 9 13 484 488 O
have 14 18 489 493 O
at 19 21 494 496 O
least 22 27 497 502 O
one 28 31 503 506 O
confirmed 32 41 507 516 O
and 42 45 517 520 O
evaluable 46 55 521 530 O
tumor 56 61 531 536 B-cancer
site 62 66 537 541 O

Patients 0 8 542 550 O
with 9 13 551 555 O
documented 14 24 556 566 O
histologic 25 35 567 577 O
diagnosis 36 45 578 587 O
of 46 48 588 590 O
glioblastoma 49 61 591 603 B-chronic_disease
multiforme 62 72 604 614 I-chronic_disease
( 73 74 615 616 O
newly 74 79 616 621 O
diagnosed 80 89 622 631 O
) 89 90 631 632 O

Patients 0 8 633 641 O
with 9 13 642 646 O
significant 14 25 647 658 O
intercurrent 26 38 659 671 O
medical 39 46 672 679 O
or 47 49 680 682 O
psychiatric 50 61 683 694 B-chronic_disease
conditions 62 72 695 705 I-chronic_disease
that 73 77 706 710 O
would 78 83 711 716 O
place 84 89 717 722 O
them 90 94 723 727 O
at 95 97 728 730 O
increased 98 107 731 740 O
risk 108 112 741 745 O
or 113 115 746 748 O
affect 116 122 749 755 O
their 123 128 756 761 O
ability 129 136 762 769 O
to 137 139 770 772 O
receive 140 147 773 780 O
or 148 150 781 783 O
comply 151 157 784 790 O
with 158 162 791 795 O
treatment 163 172 796 805 B-treatment
or 173 175 806 808 O
post 176 180 809 813 B-treatment
- 180 181 813 814 I-treatment
treatment 181 190 814 823 I-treatment
clinical 191 199 824 832 I-treatment
monitoring 200 210 833 843 I-treatment

Previous 0 8 844 852 O
treatment 9 18 853 862 O
with 19 23 863 867 O
Bevacizumab 24 35 868 879 B-treatment

Radiographic 0 12 880 892 O
procedures 13 23 893 903 O
( 24 25 904 905 O
e.g. 25 29 905 909 O
, 29 30 909 910 O
Gd 31 33 911 913 O
- 33 34 913 914 O
enhanced 34 42 914 922 O
MRI 43 46 923 926 O
or 47 49 927 929 O
CT 50 52 930 932 O
scans 53 58 933 938 O
) 58 59 938 939 O
documenting 60 71 940 951 O
existing 72 80 952 960 O
lesions 81 88 961 968 O
must 89 93 969 973 O
have 94 98 974 978 O
been 99 103 979 983 O
performed 104 113 984 993 O
within 114 120 994 1000 O
three 121 126 1001 1006 B-upper_bound
weeks 127 132 1007 1012 I-upper_bound
of 133 135 1013 1015 O
treatment 136 145 1016 1025 O
on 146 148 1026 1028 O
this 149 153 1029 1033 O
research 154 162 1034 1042 O
study 163 168 1043 1048 O

Women 0 5 1049 1054 B-gender
of 6 8 1055 1057 O
childbearing 9 21 1058 1070 O
potential 22 31 1071 1080 O
and 32 35 1081 1084 O
fertile 36 43 1085 1092 O
men 44 47 1093 1096 O
who 48 51 1097 1100 O
decline 52 59 1101 1108 B-contraception_consent
to 60 62 1109 1111 I-contraception_consent
use 63 66 1112 1115 I-contraception_consent
effective 67 76 1116 1125 I-contraception_consent
contraception 77 90 1126 1139 I-contraception_consent
during 91 97 1140 1146 O
and 98 101 1147 1150 O
for 102 105 1151 1154 O
a 106 107 1155 1156 O
period 108 114 1157 1163 O
of 115 117 1164 1166 O
three 118 123 1167 1172 B-upper_bound
months 124 130 1173 1179 I-upper_bound
after 131 136 1180 1185 O
the 137 140 1186 1189 O
treatment 141 150 1190 1199 O
period 151 157 1200 1206 O

Women 0 5 1207 1212 B-gender
who 6 9 1213 1216 O
are 10 13 1217 1220 B-pregnancy
pregnant 14 22 1221 1229 I-pregnancy

female 0 6 1230 1236 B-gender
patients 7 15 1237 1245 I-gender

≥18 0 3 1246 1249 O
years 4 9 1250 1255 I-lower_bound
of 10 12 1256 1258 O
age 13 16 1259 1262 B-age

